Skip to main content

VIOLET study

VIOLET is a phase I/II trial of video-assisted thoracoscopic surgery (VATS) lobectomy versus the conventional open procedure in patients with early-stage lung cancer. The primary outcome is patient-reported physical function at 5 weeks after surgery, which the researchers hypothesize will be better with the minimal access procedure than with open lobectomy.


Data from the study indicate that video-assisted thoracic surgery (VATS) lobectomy is associated with less pain, fewer in-hospital complications, and shorter hospital stays compared with open lobectomy for early-stage lung cancer.

Eric Lim describes the findings of the VIOLET trial comparing video-assisted thoracoscopic lobectomy and open lobectomy for early-stage lung cancer (1:57).